Literature DB >> 31177462

Hypermethylated Genes of MicroRNA in Ovarian Carcinoma: Metastasis Prediction Marker Systems.

E A Filippova1, V I Loginov1,2, A M Burdennyi1, E A Braga3,4, I V Pronina1, T P Kazubskaya5, D N Kushlinskii5, D O Utkin5, M V Fridman6, D S Khodyrev7, N E Kushlinskii5.   

Abstract

We identified a group of miRNA genes whose methylation is associated with ovarian cancer metastasis. Based on these data, new markers and the systems of markers predicting tumor dissemination were selected. Using methylation-specific PCR and a representative set of 54 ovarian cancer samples, we identified 10 microRNA genes (MIR-124a-2, MIR-127, MIR-125b-1, MIR-129-2, MIR-137, MIR-193a, MIR-203a, MIR-34b/c, MIR-130b, and MIR-1258) whose methylation is associated with tumor metastasis. The greatest association was established for 4 genes: MIR-137, MIR-193a, MIR-34b/c, and MIR-130b (p<0.01). ROC analysis revealed 3 most optimal marker systems including 4-5 miRNA genes and characterized by high sensitivity (82-94%) and specificity (76-86%) at AUC=0.89-0.92. Methylation of any three genes from these systems is sufficient to predict metastasis with the specified accuracy. Detection of the group of hypermethylated miRNA genes with predictive value for ovarian cancer metastasis is of great importance for personalized treatment of the patients.

Entities:  

Keywords:  hypermethylation; marker system; metastasis; miRNA genes; ovarian cancer

Mesh:

Substances:

Year:  2019        PMID: 31177462     DOI: 10.1007/s10517-019-04465-5

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  4 in total

1.  Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.

Authors:  V I Loginov; A M Burdennyy; E A Filippova; I V Pronina; S S Lukina; T P Kazubskaya; A V Karpukhin; D S Khodyrev; E A Braga
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804

2.  Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.

Authors:  Amirreza Bitaraf; Sadegh Babashah; Masoud Garshasbi
Journal:  J Clin Lab Anal       Date:  2019-10-08       Impact factor: 2.352

Review 3.  The Role of microRNAs in Epithelial Ovarian Cancer Metastasis.

Authors:  Vu Hong Loan Nguyen; Chenyang Yue; Kevin Y Du; Mohamed Salem; Jacob O'Brien; Chun Peng
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

Review 4.  Small Non-Coding-RNA in Gynecological Malignancies.

Authors:  Shailendra Kumar Dhar Dwivedi; Geeta Rao; Anindya Dey; Priyabrata Mukherjee; Jonathan D Wren; Resham Bhattacharya
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.